Type to search

Economic Development Health Care Insider Only New Castle County News

CorriXR Therapeutics names Moorad as new CEO

Avatar photo

WILMINGTON – CorriXR Therapeutics, the gene-editing cancer drug firm spun out of ChristianaCare, has turned to Deborah Moorad, a biotech veteran who successfully grew and sold other firms, as its new chief executive. Founded by Dr. Eric Kmiec, who also heads ChristianaCare’s Gene Editing Institute and has been a leading national researcher in the use

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2023 Delaware Business Times